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In the original article, there was a mistake in Figure 4A as published. The figure text was mislabeled,
and a lane-line was missing. The corrected Figure 4 appears below.
The authors apologize for this error and state that this does not change the scientific conclusions
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FIGURE 4 | pVHL mutants differentially regulate mitochondrial protein expression, mtDNA copy number and ATP levels. (A) Western blots show HIF-1a, HIF-2a,
GLUT-1, and BNIP3 protein levels in RCC10 cells expressing empty vector (pCMV), wild type pVHL (VHL), or pVHL mutants (R200W or N78S). a-tubulin and b-actin
were used as load controls. (B) Relative expression of PHD3 mRNA in RCC10 cells described in (A), measured using RT-qPCR. Data were analyzed using the
comparative Ct method. Data are presented as mean ± S.E.M. n = 3 (n.s. p > 0.05, *p < 0.05, and ***p < 0.001). (C) Western blots show expression of
mitochondrial proteins CHCHD4 and VDAC1, and respiratory chain subunits NDUFB10 (CI), SDHA (CII), UQCRC2 (CIII), COX IV (CIV) in RCC10 cells described in
(A). pVHL expression was assessed as a control for re-expression, and b-actin and a-tubulin were used as load controls. (D) Graph shows total cellular ATP content
in RCC10 cells expressing wild type pVHL (VHL) or pVHL mutants (R200W or N78S), normalized to cell number (n = 4). (E) Graph shows mtDNA copy number in
RCC10 cells expressing pVHL variants, calculated using the ratio of expression of mitochondrial ND1 gene to the single copy nuclear gene, b2M to by RT-qPCR.
Data in (D, E) are presented as mean ± S.D. n = 6 (n.s. p > 0.05, *p < 0.05, **p < 0.01, and ***p < 0.001).Frontiers in Oncology | www.frontiersin.org September 2021 | Volume 11 | Article 7402732
